Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a rare condition following COVID-19 infection. Cardiac involvement is common and includes left ventricular systolic dysfunction, cardiac marker elevation, electrocardiogram (ECG) changes, and coronary artery dilation. This single-center retrospective cohort study compares cardiovascular disease between three major SARS-CoV-2 variants and describes the evolution of findings in medium-term follow-up. Of 69 total children (mean age 9.2 years, 58% male), 60 (87%) had cardiovascular involvement with the most common features being troponin elevation in 33 (47%) and left ventricular dysfunction in 22 (32%). Based on presumed infection timing, 61 patients were sorted into variant cohorts of Alpha, Delta, and Omicron. Hospitalization was longer for the Delta group (7.7 days) vs Alpha (5.1 days, p = 0.0065) and Omicron (4.9 days, p = 0.012). Troponin elevation was more common in Delta compared to Alpha (13/20 vs 7/25, p = 0.18), and cumulative evidence of cardiac injury (echocardiographic abnormality and/or troponin elevation) was more common in Delta (17/20) compared with Alpha (12/25, p = 0.013) or Omicron (8/16, p = 0.034). Forty-nine (77%) of the original cohort (n = 69) had no cardiac symptoms or findings beyond 3 months post-hospitalization. Cardiac MRI was performed in 28 patients (between 3 and 6 months post-hospitalization) and was normal in 25 patients (89%). The differences in the variant cohorts may be due to alteration of the immune landscape with higher severity of COVID-19 infection. Despite overall reassuring cardiac outcomes, it is important to note the variability of presentation and remain vigilant with future variants.
Similar content being viewed by others
Data Availability
No datasets were generated or analyzed during the current study.
Abbreviations
- MIS-C:
-
Multisystem inflammatory syndrome in children
- ECG:
-
Electrocardiogram
- CDC:
-
Center for disease control
- MRI:
-
Magnetic resonance imaging
References
Jone PN et al (2022) SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults: a scientific statement from the American Heart Association. Circulation 145(19):e1037–e1052
Feldstein LR et al (2020) Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 383(4):334–346
Sperotto F et al (2021) Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr 180(2):307–322
Alali A et al (2022) Vasoplegic shock represents a dominant hemodynamic profile of multisystem inflammatory syndrome following COVID-19 in children and adolescents. Pediatr Crit Care Med 23(6):e295–e299
Choe YJ et al (2023) Change in severity and clinical manifestation of MIS-C over SARS-CoV-2 variant outbreaks in Korea. J Korean Med Sci 38(30):e225
Laird-Gion J et al (2023) MIS-C across three SARS-CoV-2 variants: changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children. Eur J Pediatr 182(6):2865–2872
Koelle K et al (2022) The changing epidemiology of SARS-CoV-2. Science 375(6585):1116–1121
Kaltman J et al (2023) Six-month cardiac outcomes in children with multisystem inflammatory syndrome in children. Cardiol Young, pp 1–7
Villacis-Nunez DS et al (2021) Giant coronary aneurysms in multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. JACC Case Rep 3(13):1499–1508
Farooqi KM et al (2021) Longitudinal outcomes for multisystem inflammatory syndrome in children. Pediatrics 148(2)
Nishikubo T et al (2023) The first case in Japan of fulminant myocarditis due to multisystem inflammatory syndrome in children (MIS-C) that required mechanical circulatory support. Int Heart J 64(4):783–788
Sliwka J et al (2022) Heart transplantation as a result of pediatric inflammatory multisystem syndrome in an adolescent. Transplant Proc 54(4):1167–1168
McAree D et al (2023) Multisystem inflammatory syndrome in children (MIS-C): reduced exercise duration and capacity at six month follow-up. Pediatr Cardiol
Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). https://www.cdc.gov/mis/mis-c/hcp/index.html. Accessed 2023
CDC museum COVID-19 timeline. https://www.cdc.gov/museum/timeline/covid19.html. Accessed 2023
Wu EY, Campbell MJ (2021) Cardiac manifestations of multisystem inflammatory syndrome in children (MIS-C) following COVID-19. Curr Cardiol Rep 23(11):168
Tabatabai M et al (2023) An analysis of COVID-19 mortality during the dominancy of alpha, delta, and omicron in the USA. J Prim Care Commun Health 14:21501319231170164
Sacco K et al (2022) Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med 28(5):1050–1062
Zambrano LD et al (2022) Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years—United States, July-December 2021. MMWR Morb Mortal Wkly Rep 71(2):52–58
Chin SE et al (2022) Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 vaccination. Pediatr Cardiol 43(3):483–488
Levy M et al (2022) Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA 327(3):281–283
Zhang HP et al (2023) Recent developments in the immunopathology of COVID-19. Allergy 78(2):369–388
La Torre F et al (2023) Multi-inflammatory syndrome in children (MIS-C) in 2023: is it time to forget about it? Children 10(6):980
Author information
Authors and Affiliations
Contributions
RSK and TO conceived of the research question, performed the data analysis, and wrote the initial draft of the manuscript. SDH, AHS, BT, and AAS assisted in refining the research methods and critically reviewed and contributed to the final draft of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There are no relevant financial disclosures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Khan, R.S., Ordog, T., Hong, S.D. et al. Evolution of Cardiovascular Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Across COVID-19 Variants: Common Trends and Unusual Presentations. Pediatr Cardiol 45, 552–559 (2024). https://doi.org/10.1007/s00246-023-03397-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-023-03397-2